Aleor Derma gets USFDA nod for Antibacterial Cream: Alembic

Mupirocin Cream USP, 2% is indicated for the treatment of secondarily infected traumatic skin lesions

150
Cosmetics medicine

Last Updated on November 19, 2021 by The Health Master

Mumbai: Alembic Pharmaceuticals Limited announced that its joint venture Aleor Dermaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Mupirocin Cream USP, 2%.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Bactroban Cream, 2%, of SmithKline Beecham (Cork) Ltd, Ireland (SmithKline).

Mupirocin Cream USP, 2% is indicated for the treatment of secondarily infected traumatic skin lesions (up to 10 cm in length or 100 cm2 in area) due to susceptible strains of S. aureus and S. pyogenes.

Aleor has been granted a Competitive Generic Therapies (CGT) designation for this ANDA and it is eligible for 180 days of CGT exclusivity as it is the first approved applicant.

Mupirocin Cream USP, 2% has an estimated market size of US$ 28 million for twelve months ending Jun 2021 according to IQVIA.

Alembic has received year to date (YTD) 13 approvals (10 final approvals and 3 tentative approvals) and a cumulative total of 152 ANDA approvals (133 final approvals and 19 tentative approvals) from the USFDA.

Aleor Dermaceuticals Limited had earlier received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/gram.

Alembic Pharmaceuticals Limited is a vertically integrated research and development pharmaceutical company headquartered in Gujarat.

Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world.

USFDA gives nod to Zydus Pharma for Eluxadoline Tablets

USFDA gives final nod to Zydus Cadila for Glycopyrrolate Injection

USFDA approves Drug to treat Hyperactivity disorder

USFDA’s nod for Kerala’s local herb Manathakkali for Liver Cancer Treatment

USFDA nod for Cortrophin Gel to treat Autoimmune Disorders

Allergan gets USFDA nod for eye drop to treat blurry vision

CDSCO gives nod to Cadila for the drug to treat hyperkalemia

Pharma Industry to depend on low cost Chinese APIs due to…

No retention or renewal fees after one time registration of ASU products

PCI issues further advisory to Pharmacy Colleges regarding salaries to Teachers

A woman doing illegal MTPs arrested: Haryana

International Conference on National Education Policy will be held at …

IPC adds new impurities and Reference Standards: Download the list

Drug alert: 36 out of 1061 samples declared as NSQ in October 2021

Latest Circulars by the Govt of India, Dept of Pharmaceuticals, Health…

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news